If you follow health news or social media, you’ve likely seen that hormones are having a moment. These small chemical messengers play a vital role in the body, and research has long shown that the hormone estrogen acts as a natural shield for women’s cardiovascular health. Because of this protective role, it’s natural to wonder why doctors don’t routinely test hormone levels as a part of preventative cardiovascular care.
How Estrogen Protects the Female Heart
Estrogen helps protect a woman’s cardiovascular system in a number of ways. First, it stimulates the production of a chemical called nitric oxide, which relaxes and widens the artery walls. Wider, flexible vessels allow blood to flow easily, keeping blood pressure low.
Estrogen also influences how the liver processes fats and cholesterol in the bloodstream. It raises HDL (“good” cholesterol), which helps remove excess cholesterol before it hardens. At the same time, it lowers LDL, the “bad” cholesterol that can build up and form hard plaques that ultimately narrow artery walls. Heart attacks are often caused when plaques in the arteries become inflamed and rupture. Estrogen helps fight this inflammation.
It’s important to note that all these protective powers highly depend on the underlying health of the blood vessels. In arteries where the lining is intact, estrogen works well to keep vessels healthy. In contrast, if arteries are already damaged or calcified, adding estrogen can have an opposite effect, destabilizing plaque and increasing the risk for rupture.
The Moving Target: Where Hormone Tests Fall Short
Given these cardioprotective effects, some may wonder whether measuring women’s hormone levels before they reach menopause could serve as a useful baseline before estrogen levels begin to decline. Yet, clinical practicality presents a different picture.
In reality, hormone levels aren’t steady in healthy, pre-menopausal women. They fluctuate over a 28-day cycle. In other words, a "normal" test on day 4 looks completely different from day 14. Beyond these day-to-day shifts, stress, sleep quality, exercise and diet can cause short-term hormonal ups and downs. As a result, when women have normal menstrual cycles and are not experiencing perimenopausal or menopausal symptoms, hormone testing isn’t recommended to inform a treatment plan.
When estrogen levels stop following their typical monthly cycle and begin dropping unpredictably, perimenopause and menopause symptoms emerge. However, there isn’t an established hormone level to reliably predict when these symptoms will occur. In other words, doctors prescribe hormone therapy to relieve symptoms, not to target a specific lab number.
Tracking Smarter Metrics
While there is no established estrogen level shown to be cardioprotective, preventive cardiologists do use other stable blood markers as a window into heart health. In fact, a 2024 study on women’s heart health identified three important metrics:
- LDL-C (Low-Density Lipoprotein Cholesterol) – These microscopic packages carry fat and cholesterol through your blood; LDL-C measures the amount of “bad” cholesterol. When these levels are high, excess cholesterol particles filter through the thin inner lining of your blood vessels, get trapped inside the artery wall and trigger plaque formation. Over time, this plaque narrows your blood vessels and increases risk of a heart attack.
- LP(a) [Lipoprotein(a)] – This lipoprotein variation is genetically inherited and impacts approximately 20% of the population. Its unique structure allows it to deposit cholesterol into artery walls more aggressively than standard LDL. It is often the hidden culprit when an otherwise fit, healthy young person develops premature heart disease.
- Apoloprotein b (apoB) – This blood test estimates the number of cholesterol-carrying particles that can contribute to plaque buildup in your arteries. It can reveal additional cardiovascular risk even when LDL (“bad”) cholesterol appears normal or is at your treatment goal. ApoB testing may be especially helpful for people with high triglycerides, type 2 diabetes, or known cardiovascular disease.
- HS-CRP (High-sensitivity C-reactive Protein) – This blood test measures a marker of inflammation in the body. Inflammation contributes to the development of artery plaque and can make plaque more likely to rupture and trigger a blood clot. Higher hs-CRP levels are associated with increased risk of heart attack and stroke, including in women whose cholesterol levels appear normal. The result adds information to—not replaces—cholesterol testing and an overall cardiovascular risk assessment.
When discussing heart disease prevention with your clinician, consider asking about these tests. Unlike fluctuating hormone levels, they may offer insightful information you and your care team can use to be proactive about your health.
The Bottom Line: Protecting Your Heart
As research in female health continues to evolve, so will our understanding of heart disease in women. Future studies may uncover more reliable ways to measure hormone sensitivity. But based on today’s data, the best early preventative strategy is still knowing your numbers. In addition to LDL-C, Lp(a), apoB and hs-CRP, stay up to date on your blood pressure, blood sugar, weight, and other cardiovascular risk factors. Understanding your personal risk will empower you to make heart-healthy choices today and for years to come!
